Skip to main content

Advertisement

Table 1 Patient characteristics

From: Impaired mitochondrial β-oxidation in patients with chronic hepatitis C: relation with viral load and insulin resistance

  Patients Reference value
Age (yr) b 54.2 ± 10.6  
Male/Female (ratio) 14/16 (0.47)  
BMI (kg/m2) b 23.7 ± 2.7 18.5 - 25
ALT (IU/L) a 47.5 (17–167) 8 - 42
γGTP (IU/L) a 41 (13–152) 10 - 47
ChE (IU/L) b 312.9 ± 88.2 185 - 431
Fasting plasma glucose (mg/dL) b 95.5 ± 9.7 70 - 109
Insulin (μIU/mL) a 8.7 (4.5 - 20.4) 1.84 - 12.2
HOMA-IR a 2.0 (1.2 - 5.1)  
HOMA-IR > 2.5 (%) 9 (30)  
Triglyceride (mg/dL) b 91.4 ± 31.1 30 - 149
Total cholesterol (mg/dL) b 175.2 ± 25.4 129 - 219
Acylcarnitine (μmol/L) a 9.25 (5.7 - 21.1) 6 - 23
HCV RNA (LogIU/mL) b 6.1 ± 0.9  
HCV core antigen (fmol/L) a 6505 (<20–23200)  
HCV Genotype 1b / 2a / 2b 20 / 6 / 4  
Inflammation A0 / A1 / A2 / A3 0 / 15 / 10 / 0  
Fibrosis F0 / F1 / F2 / F3 / F4 0 / 15 / 7 / 3 / 0  
Steatosis G0 / G1 / G2 / G3 6 /18 / 1 / 0  
  1. BMI, body mass index; ALT, alanine aminotransferase; γGTP, gamma-glutamyltranspeptidase; ChE, cholinesterase; HOMA-IR, homeostasis model assessment of insulin resistance.
  2. Data are amedians (min-max), bthe means ± standard deviation.